Halma plc (LON:HLMA) Stock Rated “Moderate Buy” by Wall Street Analysts

Halma plc (LON:HLMA) has received an average recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is £6,003.71.

A number of brokerages have weighed in on HLMA. Jefferies Financial Group restated a “hold” rating and issued a GBX 3,660 price objective on shares of Halma in a report on Friday, September 25th. Berenberg Bank restated a “buy” rating and issued a GBX 4,200 price target on shares of Halma in a research note on Thursday, July 16th.

Insider Transactions at Halma

In other Halma news, insider Marc Ronchetti sold 47,000 shares of the business’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of GBX 3,813, for a total value of £1,792,110. Insiders own 0.82% of the company’s stock.

Halma Stock Performance

Shares of Halma stock opened at GBX 3,480 on Thursday. Halma has a 12 month low of GBX 3,198 and a 12 month high of GBX 4,902. The firm has a market capitalization of £13.14 billion, a P/E ratio of 35.45, a P/E/G ratio of 2.93 and a beta of 0.97. The company has a current ratio of 2.14, a quick ratio of 1.51 and a debt-to-equity ratio of 42.13. The business has a fifty day simple moving average of GBX 3,501.72 and a two-hundred day simple moving average of GBX 3,855.72.

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.